Review



atf3 inducer 1  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress atf3 inducer 1
    A The appearance of femoral heads in control, GIONFH model (Dex), and <t>ATF3</t> inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 <t>inducer</t> <t>1</t> administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.
    Atf3 Inducer 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atf3 inducer 1/product/MedChemExpress
    Average 93 stars, based on 4 article reviews
    atf3 inducer 1 - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "Pentraxin 3 ameliorates glucocorticoid-induced osteonecrosis of the femoral head via TLR4/NF-κB/FGF21 signaling axis"

    Article Title: Pentraxin 3 ameliorates glucocorticoid-induced osteonecrosis of the femoral head via TLR4/NF-κB/FGF21 signaling axis

    Journal: Communications Biology

    doi: 10.1038/s42003-025-09282-3

    A The appearance of femoral heads in control, GIONFH model (Dex), and ATF3 inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 inducer 1 administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.
    Figure Legend Snippet: A The appearance of femoral heads in control, GIONFH model (Dex), and ATF3 inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 inducer 1 administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.

    Techniques Used: Control, Staining, Immunohistochemistry, Immunohistochemical staining, Expressing, Standard Deviation, Knock-Out, Disruption



    Similar Products

    93
    MedChemExpress atf3 inducer 1
    A The appearance of femoral heads in control, GIONFH model (Dex), and <t>ATF3</t> inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 <t>inducer</t> <t>1</t> administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.
    Atf3 Inducer 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atf3 inducer 1/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    atf3 inducer 1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress atf3 inducer 1 group
    A The appearance of femoral heads in control, GIONFH model (Dex), and <t>ATF3</t> inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 <t>inducer</t> <t>1</t> administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.
    Atf3 Inducer 1 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atf3 inducer 1 group/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    atf3 inducer 1 group - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress press atf3 inducer 1 group
    A The appearance of femoral heads in control, GIONFH model (Dex), and <t>ATF3</t> inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 <t>inducer</t> <t>1</t> administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.
    Press Atf3 Inducer 1 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/press atf3 inducer 1 group/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    press atf3 inducer 1 group - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress atf3 inducer
    A The appearance of femoral heads in control, GIONFH model (Dex), and <t>ATF3</t> inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 <t>inducer</t> <t>1</t> administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.
    Atf3 Inducer, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atf3 inducer/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    atf3 inducer - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    A The appearance of femoral heads in control, GIONFH model (Dex), and ATF3 inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 inducer 1 administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.

    Journal: Communications Biology

    Article Title: Pentraxin 3 ameliorates glucocorticoid-induced osteonecrosis of the femoral head via TLR4/NF-κB/FGF21 signaling axis

    doi: 10.1038/s42003-025-09282-3

    Figure Lengend Snippet: A The appearance of femoral heads in control, GIONFH model (Dex), and ATF3 inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 inducer 1 administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.

    Article Snippet: The ATF3 inducer 1 group received additional intraperitoneal administrations of 4 mg/kg ATF3 inducer 1 (HY-151923, MedChemExpress) twice a week over the same 8-week period.

    Techniques: Control, Staining, Immunohistochemistry, Immunohistochemical staining, Expressing, Standard Deviation, Knock-Out, Disruption

    A The appearance of femoral heads in control, GIONFH model (Dex), and ATF3 inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 inducer 1 administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.

    Journal: Communications Biology

    Article Title: Pentraxin 3 ameliorates glucocorticoid-induced osteonecrosis of the femoral head via TLR4/NF-κB/FGF21 signaling axis

    doi: 10.1038/s42003-025-09282-3

    Figure Lengend Snippet: A The appearance of femoral heads in control, GIONFH model (Dex), and ATF3 inducer 1-treated groups. B HE staining of femoral heads in three groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). C IHC staining of ALP, OCN and COL1 in three groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). D The appearance of femoral heads in ATF3 inducer 1-treated WT and Ptx3 -KO groups. E HE staining of femoral heads in both groups and quantitative analysis of the results of HE staining (n = 5 technical replicates). F IHC staining of ALP, OCN and COL1 in both groups and quantitative analysis of immunohistochemical positive expression in each group of mice. (n = 3 technical replicates). Statistical analysis: Dunnett’s post-hoc tests. Error bars: standard deviation, SD. Control: vehicle-treated, n = 5; Dex: GIONH model, n = 5; Dex+ATF3/ Ptx3 +/+ +ATF3: GIONFH model with 40 mg/kg ATF3 inducer 1 administration twice a week, n = 5; Ptx3 −/− +ATF3: Ptx3 -knockout mice with GIONFH modeling and ATF3 inducer 1, n = 5. Red arrows: empty lacunae; Black arrows: trabecular bone disruption; Star symbol: necrotic bone marrow; White arrows: positive cells. The images provided in all figures represent typical examples from each experimental group.

    Article Snippet: The ATF3 inducer 1 group received additional intraperitoneal administrations of 4 mg/kg ATF3 inducer 1 (HY-151923, MedChemExpress) twice a week over the same 8-week period.

    Techniques: Control, Staining, Immunohistochemistry, Immunohistochemical staining, Expressing, Standard Deviation, Knock-Out, Disruption